BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Hong_Kong
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:HKT
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260423
DTEND;VALUE=DATE:20260424
DTSTAMP:20260505T095210
CREATED:20260131T002014Z
LAST-MODIFIED:20260131T002021Z
UID:10000650-1776902400-1776988799@oncodaily.com
SUMMARY:Escalation or De-Escalation? Strategies in HER2+ Breast Cancer Treatment
DESCRIPTION:The webinar titled “Escalation or de-escalation? Strategies in HER2+ breast cancer treatment” is scheduled to take place on April 23\, 2026\, at 18:00 CEST. Organized by OncoCorner and Sharing Progress in Cancer Care (SPCC)\, this educational session focuses on optimizing neo/adjuvant treatment strategies for HER2-positive breast cancer. \nThe discussion\, featuring experts Roisin Connolly and Adrienne G. Waks\, will cover current standards of care\, the individualization of treatment based on clinical evidence\, and the implications for surgical decision-making in a multidisciplinary setting. Discussant Alexandru Eniu will lead the session\, which has received funding from the European Union’s Horizon Europe program and the Swiss State Secretariat for Education\, Research and Innovation (SERI)\, with CME accreditation currently in progress.
URL:https://oncodaily.com/event/breast-cancer-treatment-449709
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/SPCC-7.webp
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260309
DTEND;VALUE=DATE:20260310
DTSTAMP:20260505T095210
CREATED:20260118T190819Z
LAST-MODIFIED:20260118T190827Z
UID:10000595-1773014400-1773100799@oncodaily.com
SUMMARY:Minimal Residual Disease in Multiple Myeloma: Future Directions and Controversies
DESCRIPTION:The webinar “Minimal Residual Disease in Multiple Myeloma: Future Directions and Controversies” is a high-level clinical session scheduled for March 9\, 2026\, at 18:00 CET. \nServing as the second installment of a specialized series by SPCC (Sharing Progress in Cancer Care)\, this activity moves beyond foundational knowledge to tackle the most debated aspects of MRD in current oncology. Led by a panel of international experts including Jesús San-Miguel\, Luciano Costa\, and Elena Zamagni\, the discussion will focus on the feasibility of MRD-driven treatment de-escalation\, the challenge of spatial heterogeneity\, and the integration of imaging with molecular techniques.
URL:https://oncodaily.com/event/minimal-residual-disease-443045
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/SPCC-4.webp
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260225
DTSTAMP:20260505T095210
CREATED:20260126T225512Z
LAST-MODIFIED:20260126T225524Z
UID:10000631-1771891200-1771977599@oncodaily.com
SUMMARY:Innovations and Clinical Advances in Radioligand Therapy
DESCRIPTION:The OncoCorner webinar\, titled “Innovations and clinical advances in radioligand therapy\,” is scheduled for Tuesday\, February 24\, 2026\, starting at 18:00 CET. This session explores the rapid evolution of Radioligand Therapy (RLT)\, focusing on how translational research is enhancing targeting precision and integrating nuclear medicine more deeply into modern oncology. \nParticipants will gain insights into current capabilities at leading cancer centers\, expected breakthroughs over the next several years\, and the most promising emerging agents in the RLT landscape. The event features an expert panel consisting of Antoine Leimgruber\, Saverio Braccini\, Anne-Laure Giraudet\, and Niklaus Schaefer\, and is supported by Sharing Progress in Cancer Care (SPCC) as part of its Sustaining Corporate Programme.
URL:https://oncodaily.com/event/radioligand-therapy-447592
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/SPCC-6.webp
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260211
DTEND;VALUE=DATE:20260212
DTSTAMP:20260505T095210
CREATED:20260117T193624Z
LAST-MODIFIED:20260117T193632Z
UID:10000589-1770768000-1770854399@oncodaily.com
SUMMARY:Minimal Residual Disease in Multiple Myeloma: Foundations and Clinical Relevance
DESCRIPTION:The SPCC (Sharing Progress in Cancer Care) webinar\, titled “MRD in multiple myeloma: foundations and clinical relevance\,” is a high-level educational session scheduled for February 11\, 2026. \nAs Minimal Residual Disease (MRD) transitions from a clinical trial endpoint to a critical tool for personalized oncology\, this webinar aims to bridge the gap between scientific theory and daily clinical practice. Led by a panel of world-renowned experts\, the session will explore how ultra-sensitive detection technologies – capable of identifying a single cancer cell among a million healthy ones – are redefining what it means for a patient to be in “remission.”
URL:https://oncodaily.com/event/minimal-residual-disease-442403
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/SPCC-3.webp
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260202
DTEND;VALUE=DATE:20260203
DTSTAMP:20260505T095210
CREATED:20260118T190217Z
LAST-MODIFIED:20260118T190245Z
UID:10000594-1769990400-1770076799@oncodaily.com
SUMMARY:Optimising the Treatment Pathway in HER2+ Breast Cancer: From Neoadjuvant Therapy to Surgery
DESCRIPTION:The webinar “Optimising the treatment pathway in HER2-positive breast cancer: from neoadjuvant therapy to surgery” is a specialized educational session scheduled for February 2\, 2026\, at 18:00 CET. \nPart of the European Union-funded DEFINITIVE project\, this session examines the critical interface between systemic neoadjuvant management and evolving surgical standards for HER2-positive breast cancer. A multidisciplinary panel\, including experts Monika Gräser and Gaia Griguolo with discussant Aleksandra Filipovic\, will address evidence-based strategies for tailoring therapy and the clinical implications of treatment response on surgical decision-making.
URL:https://oncodaily.com/event/breast-cancer-443034
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/OncoDaily-SPCC.webp
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260122
DTEND;VALUE=DATE:20260123
DTSTAMP:20260505T095210
CREATED:20251221T170051Z
LAST-MODIFIED:20251221T170328Z
UID:10000514-1769040000-1769126399@oncodaily.com
SUMMARY:Highlights from ABC 8 - International Consensus Guidelines for Advanced Breast Cancer management
DESCRIPTION:The Sharing Progress in Cancer Care (SPCC)\, in collaboration with the ABC Global Alliance\, is hosting a live webinar titled “Highlights from ABC 8 – International Consensus Guidelines for Advanced Breast Cancer Management“ on Thursday\, January 22\, 2026\, at 18:00 CET. \nThis session is specifically designed to provide essential updates for those unable to attend the ABC 8 conference in person\, covering critical advancements in the management of ER+/HER2-negative\, HER2-positive\, and triple-negative advanced breast cancer. \nFeaturing renowned experts such as Fatima Cardoso\, Alexandru Eniu\, and Shani Paluch-Shimon\, the webinar aims to translate the latest international consensus guidelines into clinical practice through expert discussion and an interactive Q&A session. \n \nYou can also read more posts featuring SPCC and the ABC Global Alliance on OncoDaily.
URL:https://oncodaily.com/event/abc-8-432225
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/SPCC-1.webp
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251204
DTEND;VALUE=DATE:20251205
DTSTAMP:20260505T095210
CREATED:20251114T212751Z
LAST-MODIFIED:20251114T212802Z
UID:10000354-1764806400-1764892799@oncodaily.com
SUMMARY:Anti-HER2 Therapies: Biological Mechanisms and Toxicity Management
DESCRIPTION:The event “Anti-HER2 therapies: biological mechanisms and toxicity management“ is a live webinar scheduled for December 4\, 2025\, at 18:00 CET. \nThis online educational session is focused on breast cancer and will feature experts who will discuss the molecular mechanisms that underpin HER2-targeted treatments and their role in improving patient outcomes\, while also providing a comprehensive and practical overview of the challenges and strategies for managing therapy-related toxicities. \nThe webinar aims to enhance the knowledge of clinicians and researchers involved in the care of patients with HER2-positive breast cancer.
URL:https://oncodaily.com/event/anti-her2-therapies-409787
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/SPCC.jpg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251126T180000
DTEND;TZID=America/Halifax:20251126T190000
DTSTAMP:20260505T095210
CREATED:20251015T161227Z
LAST-MODIFIED:20251015T161242Z
UID:10000279-1764180000-1764183600@oncodaily.com
SUMMARY:The Secondary Use of Health Data\, Digital Twins to Improve Clinical Trials
DESCRIPTION:Digital health and artificial intelligence are reshaping the landscape of clinical care and patient engagement. This session will examine how these technologies are advancing decision-making\, enabling more personalized treatment\, and enhancing the overall patient experience. Leading experts will offer their insights on current innovations and future developments in this rapidly evolving field. \n\n18.00 – CET Introduction – Antonio Marra\, IT\n18.05 – CET Harnessing real-world data and digital twins to enhance oncology clinical trials – Arsela Prelaj\, IT\n18.25 – CET Regulatory and ethical pathways for the secondary use of health data in the EU – Mélodie Bernaux\, BE\n18.45 – CET Discussion and Q&A\n18.55 – CET Closing remarks – Antonio Marra\, IT\n\n \nThis session is part of the SPCC Sustaining Corporate Programme 2025. \nSharing Progress in Cancer Care wishes to extend appreciation to its Sustaining Companies for providing unrestricted educational support to the following webinar. Companies have no control over the session content or speakers. \n \nYou can find more posts featuring SPCC on OncoDaily.
URL:https://oncodaily.com/event/health-data-391049
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/10/SPCC-Trials.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251028T180000
DTEND;TZID=America/Halifax:20251028T190000
DTSTAMP:20260505T095210
CREATED:20251015T161010Z
LAST-MODIFIED:20251015T161123Z
UID:10000278-1761674400-1761678000@oncodaily.com
SUMMARY:HER2 Positive Breast Cancer: Pathological and Molecular Perspectives
DESCRIPTION:This webinar provides an in-depth exploration of HER2-positive breast cancer\, covering both the pathological and molecular dimensions of the disease. Attendees will gain expert perspectives on the latest developments in tumour biology\, molecular profiling\, and diagnostic techniques\, as well as their influence on clinical decision-making and patient management. The session aims to deliver a clear and current understanding of HER2-positive breast cancer\, emphasizing how advances in research and pathology contribute to more personalized treatment strategies. \n\n18:00-18:05 | Welcome and introduction – Aleksandra Filipovic\, UK\n18:05-18:25 | HER2 positive breast cancer. The pathological perspective – Esther Sanfeliu\, ES\n18:25-18:45 | HER2 positive breast cancer. Molecular perspective – Mattia Rediti\, IT\n18:45-18:55 | Discussion and Q&A\n18:55-19:00 | Closure – Aleksandra Filipovic\, UK\n\n \nFunded by the European Union – Horizon Europe Grant Agreement No. 101136953. \nViews and opinions expressed are however\, those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them. \nThis work has also received funding from the Swiss State Secretariat for Education\, Research and Innovation (SERI). \n \nYou can find more posts featuring SPCC on OncoDaily.
URL:https://oncodaily.com/event/breast-cancer-391036
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/10/SPCC-BC.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250923T180000
DTEND;TZID=America/Halifax:20250923T190000
DTSTAMP:20260505T095210
CREATED:20250826T151053Z
LAST-MODIFIED:20250826T153019Z
UID:10000249-1758650400-1758654000@oncodaily.com
SUMMARY:SPCC Webinar on "Advances in Breast Cancer: Epidemiology and Early Diagnosis"
DESCRIPTION:The webinar titled “Advances in Breast Cancer: Epidemiology and Early Diagnosis“ will be held on September 23\, 2025\, at 18:00 CEST. Organized by SPCC\, this Webinar will provide an overview of the latest developments in breast cancer. \nExperts will share updated insights on current trends in incidence\, risk factors\, and global disparities\, as well as advances in diagnostic techniques and strategies for early detection. Featuring Paola Clauser (AT) and Elisabetta Munzone (IT)\, the webinar will be moderated by Matti Aapro (CH). Learn more and register.
URL:https://oncodaily.com/event/breast-cancer-356185
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/08/OncoDaily-43-1.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250416T080000
DTEND;TZID=America/Halifax:20250416T170000
DTSTAMP:20260505T095210
CREATED:20250330T204427Z
LAST-MODIFIED:20250607T193756Z
UID:10000191-1744790400-1744822800@oncodaily.com
SUMMARY:From policy frameworks to real-world implementation: a call to action by SPCC
DESCRIPTION:From policy frameworks to real-world implementation: a call to action by SPCC will be held on April 16\, 2025\, Virtually. \nThis comprehensive course includes three educational modules and a live interactive webinar\, focusing on key opportunities\, challenges\, and best practices in Data Policy and Management in Cancer Care. \nExpert speakers for the course include Pisani Eduardo\, Presti Pietro\, Garcia-Foncillas López Jesús\, Hickey Matt\, and Saunders Christobel\, who will share their insights on navigating the complexities of cancer care\, optimizing data management\, and improving patient outcomes through innovative strategies. This training provides a valuable opportunity for professionals to enhance their skills and understanding in this critical area of cancer care.
URL:https://oncodaily.com/event/spcc264197
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/03/Post-1-e1743367004671.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250407T130000
DTEND;TZID=America/Halifax:20250407T170000
DTSTAMP:20260505T095210
CREATED:20250323T144906Z
LAST-MODIFIED:20250607T194753Z
UID:10000187-1744030800-1744045200@oncodaily.com
SUMMARY:Tackling oncology inequalities: Addressing social drivers of health in LMICs and Africa by SPCC
DESCRIPTION:Tackling oncology inequalities: addressing social drivers of health in LMICs and Africa by SPCC will be held on April 7th\, 2025\, Virtually.\nThe event organized by SPCC focuses on the urgent need for health equity in cancer care\, particularly in low- and middle-income countries (LMICs) and Africa. It will address the impact of social determinants like socioeconomic status\, race\, and access to healthcare on cancer outcomes. The discussion will emphasize the importance of overcoming these barriers\, expanding access to treatment\, and ensuring equal care for all patients\, regardless of background. \nSpeakers at the event\, including Keefe Dorothy\, Ibraheem Abiola\, and Ilbawi André\, will share insights on tackling these inequalities\, advocating for strategies that promote health equity in oncology and improve outcomes for marginalized populations. \nRead more about SPCC at OncoDaily.com.\n 
URL:https://oncodaily.com/event/spcc259472
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/03/spcc-2-e1742642489735.jpeg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250401T080000
DTEND;TZID=America/Halifax:20250401T170000
DTSTAMP:20260505T095210
CREATED:20250327T092822Z
LAST-MODIFIED:20250607T194830Z
UID:10000189-1743494400-1743526800@oncodaily.com
SUMMARY:How to implement efficiency in Cancer Care by SPCC
DESCRIPTION:“Efficiency implementation in the cancer care continuum: data\, metrics and best practices by SPCC” course includes three educational modules.\n“How to implement efficiency in Cancer Care by SPCC” is one of the modules that will be held on April 1st\, 2025\, Virtually. \nThe event will address key challenges\, opportunities\, and best practices in managing cancer-related data\, aiming to improve patient outcomes and streamline care delivery. \nThe event will feature expert speakers\, including Pisani Eduardo\, Bowers Liora\, Garcia-Foncillas López Jesús\, and Normanno Nicola\, who will provide valuable insights and practical strategies for navigating the complexities of cancer care. This collaboration offers professionals an opportunity to deepen their understanding of cancer care management and learn how to implement data-driven approaches to enhance treatment and patient care in an ever-evolving healthcare landscape. \n 
URL:https://oncodaily.com/event/spcc261454
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/03/Efficiency-3-Module-Post-1-e1743067490580.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250317T180000
DTEND;TZID=America/Halifax:20250317T190000
DTSTAMP:20260505T095210
CREATED:20250208T114404Z
LAST-MODIFIED:20250607T195050Z
UID:10000136-1742234400-1742238000@oncodaily.com
SUMMARY:Breaking barriers: ensuring equal cancer care access for diverse communities by SPCC
DESCRIPTION:Breaking barriers: ensuring equal cancer care access for diverse communities by SPCC will be held at March 17\, 2025\, Virtually. \nThis event focuses on addressing health disparities in cancer care and the importance of achieving health equity for all patients. It highlights the significant impact of social drivers of health such as socioeconomic status\, race\, and access to resources on patient outcomes\, caregivers\, and clinical teams. The session will explore how these barriers can be overcome to ensure equal access to treatment and care for everyone\, regardless of their background. \nThe event features presentations from experts\, including Nicolò Matteo Luca Battisti\, Joseph Gligorov\, and Stewart O’Callaghan. The discussions aim to shed light on successful initiatives\, explore how far we’ve come in fostering equality in cancer care\, and identify the next steps needed to make further progress. \n 
URL:https://oncodaily.com/event/240618
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/SPCC-2.jpg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20250312T090000
DTEND;TZID=Europe/Helsinki:20250312T090000
DTSTAMP:20260505T095210
CREATED:20241020T203931Z
LAST-MODIFIED:20250607T195031Z
UID:10000048-1741770000-1741770000@oncodaily.com
SUMMARY:Improving care of Early Breast Cancer (EBC) patients in Europe Investigators Meeting by SPCC
DESCRIPTION:Improving care of Early Breast Cancer (EBC) patients in Europe Investigators Meeting by SPCC will be held at Vienna\, Austria at 12 March 2025. \n\n\n\n\nThis activity\, supported by Eli Lilly and Company in collaboration with SPCC\, was designed to bring together healthcare professionals and innovative organizations to identify gaps in the treatment of Early Breast Cancer and develop strategies to improve care and address those gaps. The initiative aimed to facilitate the involvement of patients\, caregivers\, and families in collaborative decision-making processes\, while also employing evidence-based educational strategies aligned with the desired outcomes of the intervention. \n\n\n\n\n\n 
URL:https://oncodaily.com/event/167878
LOCATION:Vienna\, Austria\, Vienna\, 1300\, Austria
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Untitled-24-1.jpg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20250307T070000
DTEND;TZID=Europe/Helsinki:20250308T170000
DTSTAMP:20260505T095210
CREATED:20241020T203849Z
LAST-MODIFIED:20250607T195012Z
UID:10000051-1741330800-1741453200@oncodaily.com
SUMMARY:Strategic Leading and Management in the Cancer Care Continuum by SPCC
DESCRIPTION:Basic skills in “Strategic Leading and Management in the Cancer Care Continuum” by SPCC will be held from March 7-8\, 2025 at Milan\, Italy. \nThe leadership and management skills in the Cancer Care Continuum are becoming increasingly important for medical and clinical staff\, as they must be prepared to address the challenges\, dynamics\, and complexity of modern healthcare. This includes fast-paced technological advancements\, growing patient needs\, and limited resources\, particularly in oncology. \nIn response\, SPCC plans to launch a basic course in “Strategic Leading and Management in the Cancer Care Continuum.” This educational program is designed to enhance participants’ understanding of management skills and develop the capabilities needed to become effective leaders in the field. \nRegistration is open for the event.
URL:https://oncodaily.com/event/168603
LOCATION:Milan\, Italy
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Strategic-Leading-Slide-1.jpg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250305T180000
DTEND;TZID=America/Halifax:20250305T190000
DTSTAMP:20260505T095210
CREATED:20250208T111251Z
LAST-MODIFIED:20250608T085957Z
UID:10000131-1741197600-1741201200@oncodaily.com
SUMMARY:People\, places\, and platforms that support a cancer patient’s journey by SPCC
DESCRIPTION:People\, places\, and platforms that support a cancer patient’s journey by SPCC will be held at March 5\, 2025\, Virtually. \nThis conference focuses on the various people\, places\, and platforms that support a cancer patient’s journey. It highlights the importance of a comprehensive support network that goes beyond medical treatment. Compassionate healthcare professionals\, supportive family members\, specialized medical centers\, and digital innovations all play a vital role in providing comfort\, guidance\, and resources. \nThese interconnected elements help empower patients to face their cancer journey with resilience and strength. The session will feature speakers Aleksandra Filipovic\, Steve Bierman\, and Alejandro Piris\, who will share their insights on how these diverse forms of support contribute to improving patient outcomes.
URL:https://oncodaily.com/event/239077
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/Webinar_05_Mar_Banner_Newsletter.jpg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250129T180000
DTEND;TZID=America/Halifax:20250129T210000
DTSTAMP:20260505T095210
CREATED:20250113T170456Z
LAST-MODIFIED:20250608T082151Z
UID:10000117-1738173600-1738184400@oncodaily.com
SUMMARY:Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC
DESCRIPTION:Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC will be held at January 29th\, 2025 at 6 pm. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe Outlook for the HR+/HER2- MBC Treatment Landscape in 2025 and Beyond Live Webinar will focus on the latest advancements and future directions in treating HR+ HER2- metastatic breast cancer (MBC). Experts will review recent clinical trial data\, discuss the current treatment landscape\, and explore the role of novel therapies\, including CDK4/6 inhibitors\, PI3K inhibitors\, and targeted therapies. The evolving landscape will also include next-generation treatments that could reshape patient care in the coming years. \nBiomarker testing plays a central role in guiding treatment decisions for HR+ HER2- MBC\, and the conference will cover how genomic tests and liquid biopsies\, such as ctDNA\, can help personalize therapies. A discussion will also take place on the balance between biomarker-driven therapies versus non-biomarker approaches\, addressing when and how each strategy should be utilized in clinical practice. \nThe conference will also focus on optimizing treatment sequencing based on clinical characteristics such as tumor burden\, mutational status\, and patient performance. Esteemed speakers include Dr. Martin Miguel (Hospital General Universitario Gregorio Marañón\, Spain)\, Dr. Neven Patrick (Universitaire Ziekenhuizen Leuven\, Belgium)\, and Dr. Joyce O’Shaughnessy (Baylor-Sammons Cancer Center\, USA)\, who will share their expertise on the latest research and treatment strategies for HR+ HER2- MBC.
URL:https://oncodaily.com/event/222894
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/WhatsApp-Image-2025-01-12-at-16.20.43.jpeg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Hong_Kong:20250115T140000
DTEND;TZID=Asia/Hong_Kong:20250115T160000
DTSTAMP:20260505T095210
CREATED:20250106T184225Z
LAST-MODIFIED:20250608T082104Z
UID:10000114-1736949600-1736956800@oncodaily.com
SUMMARY:2025 CACA-OncoDaily-SPCC Cancer Summit: Bridging Continents
DESCRIPTION:The Cancer Summit\, organized by the China Anti-Cancer Association (CACA)\, OncoDaily\, Sharing Progress in Cancer Care (SPCC)\, and the World Association for Integrative Oncology (WAIO)\, will take place on January 15\, 2025 via Zoom and will feature simultaneous translation in English and Chinese. \nThe summit will be held at the following times: \n\nChina Standard Time: 02:00-04:00pm\nUS EST: 01:00-03:00am\nCentral European Time: 07:00-09:00am\n\nThe event highlights the crucial rule of collaboration in tackling the current challenges faced in oncology. \nRead more about the event here.
URL:https://oncodaily.com/event/caca-oncodaily-spcc-cancer-summit218610
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/5.1-2025-CACA-Oncodaily-SPCC-Cancer-Summit-Poster.jpg
ORGANIZER;CN="the China Anti-Cancer Association (CACA)":MAILTO:intl@caca.org.cn
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241219T180000
DTEND;TZID=America/Halifax:20241219T190000
DTSTAMP:20260505T095210
CREATED:20241120T054234Z
LAST-MODIFIED:20250608T082053Z
UID:10000072-1734631200-1734634800@oncodaily.com
SUMMARY:Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC
DESCRIPTION:Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC will be held at December 19\, 2024. \nThis live webinar will start with an introduction by Nadia Harbeck from Germany\, setting the stage for the evening’s discussions. Shani Paluch-Shimon from Israel will then present the latest updates on Early Breast Cancer (EBC) from the 2024 San Antonio Breast Cancer Symposium\, covering key advancements and findings. Following this\, Fatima Cardoso from Portugal will provide insights into the updates on Advanced Breast Cancer (ABC) presented at the same symposium\, highlighting new developments and treatments in this area. \nAfter the presentations\, there will be a 20-minute discussion and Q&A session where participants can engage with the speakers and ask questions. The event will conclude with closing remarks from Nadia Harbeck\, summarizing the key points and takeaways from the session. \nFor more information about the 2024 San Antonio Breast Cancer Symposium\, visit here.
URL:https://oncodaily.com/event/188395
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/Webinar_19_Dec_1920x1080.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241218T180000
DTEND;TZID=America/Halifax:20241218T190000
DTSTAMP:20260505T095210
CREATED:20241120T054210Z
LAST-MODIFIED:20250608T082036Z
UID:10000073-1734544800-1734548400@oncodaily.com
SUMMARY:Haemato-oncology highlights from 66th ASH Annual Meeting by SPCC
DESCRIPTION:Haemato-oncology highlights from 66th ASH Annual Meeting by SPCC will be held at December 18\, 2024. \nThis live webinar serves as a crucial platform for oncologists to stay informed about the latest research and breakthroughs in haemato-oncology\, with key highlights from the ASH meeting. By providing insights into recent advancements\, the webinar aims to deepen participants’ understanding\, enhance their education\, and promote best practices in haematology\, ultimately contributing to improved patient care in the field. \nThe webinar will begin with an introduction by Jakob Passweg from Switzerland. David Gomez-Almaguer from Mexico will then present the latest highlights in stem cell transplantation and leukemia. Following that\, Phillip Scheinberg from Brazil will provide key updates on bone marrow failure. After the presentations\, there will be a discussion and Q&A session. The event will conclude with closing remarks by Jakob Passweg. \nFor more information about\, the 66th ASH Annual Meeting visit here. \nSee the Speakers of this event below:\n \nJakob Passweg \n \n David Gomez-Almaguer \n \nPhillip Scheinberg \n  \n  \n 
URL:https://oncodaily.com/event/188403
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/Webinar_18_Dec_Banner_Newsletter.jpg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241217T180000
DTEND;TZID=America/Halifax:20241217T190000
DTSTAMP:20260505T095210
CREATED:20241129T195622Z
LAST-MODIFIED:20250608T082031Z
UID:10000081-1734458400-1734462000@oncodaily.com
SUMMARY:Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024\, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC
DESCRIPTION:Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024\, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC will be held at December 17th\, 2024. \nJoin this Live Webinar on advancements in gastrointestinal (GI) cancer care\, featuring experts Van Cutsem Eric\, Neuzillet Cindy\, and Ruiz-Garcia Erika. The event will explore recent breakthroughs in minimally invasive surgery\, targeted therapies\, and immunotherapy\, which are improving survival rates. The speakers will discuss how molecular insights are driving personalized treatment and transforming patient outcomes. Don’t miss this opportunity to learn about the latest developments and future directions in GI cancer care. \nThe webinar will begin with an introduction by Eric Van Cutsem (BE)\, setting the stage for the discussions on the latest advancements in immuno-oncology for gastrointestinal cancers. Cindy Neuzillet (FR) will then present on the progress of immuno-oncology in biliary and pancreatic cancers\, highlighting the most recent breakthroughs and clinical developments in these challenging and often difficult-to-treat cancers. Following this\, Erika Ruiz Garcia (MX) will focus on the advances in immuno-oncology for colorectal and stomach cancer\, exploring how emerging therapies are improving outcomes for patients with these common malignancies. \nAfter the presentations\, there will be an open discussion and Q&A session\, where attendees can engage directly with the speakers\, ask questions\, and share insights. The webinar will conclude with closing remarks from Eric Van Cutsem (BE)\, summarizing the key points discussed and providing a forward-looking perspective on the future of immuno-oncology in GI cancer care. This session promises to be an informative and interactive opportunity for healthcare professionals and researchers to learn about the latest advancements in this rapidly evolving field. \nLink to register and access the session. \n 
URL:https://oncodaily.com/event/194185
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/Webinar_17_Dec_1920x1080.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241127T180000
DTEND;TZID=America/Halifax:20241127T193000
DTSTAMP:20260505T095210
CREATED:20241120T051946Z
LAST-MODIFIED:20250608T081829Z
UID:10000071-1732730400-1732735800@oncodaily.com
SUMMARY:Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC
DESCRIPTION:Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC will be held at November 27\, 2024. \nIt is a live webinar by SPCC and the event will feature presentations on the latest advancements in breast cancer treatment\, with an introduction by Fiorita Poulakaki from Greece. Michael Gnant from Austria will discuss the de-escalation and escalation of surgery\, radiotherapy\, and adjuvant treatments. Stephen Johnston from the UK will focus on personalizing adjuvant endocrine therapy\, exploring current perspectives and future directions. Following the talks\, there will be a 10-minute discussion and Q&A session\, allowing participants to engage with the speakers. \nThe event will conclude with closing remarks by Fiorita Poulakaki\, summarizing the key takeaways.
URL:https://oncodaily.com/event/188391
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/Webinar_27_Nov_1920x1080.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241105T180000
DTEND;TZID=America/Halifax:20241105T180000
DTSTAMP:20260505T095210
CREATED:20241025T133325Z
LAST-MODIFIED:20250608T081121Z
UID:10000061-1730829600-1730829600@oncodaily.com
SUMMARY:Lung cancer highlights from the ESMO Congress 2024 by SPCC
DESCRIPTION:Lung cancer highlights from the ESMO Congress 2024 by SPCC will take place at November 5th\, 2024. \nIt is a live webinar by SPCC which will be futuring Aleksandra Filipovic\, Alfredo Addeo\, Christian Rolfo. The landscape of treatment for thoracic malignancies has undergone significant and rapid advancements in recent years. New therapies\, including targeted treatments\, immunotherapies\, and innovative surgical techniques\, are now available\, having a profound and positive impact on patients’ lives by improving outcomes and quality of care. However\, with the fast-paced development and the vast amount of clinical data being generated from ongoing research and presented at international conferences\, it can be challenging for clinicians and healthcare professionals to stay up to date with the latest evidence and treatment options. \nFor registration visit here
URL:https://oncodaily.com/event/171740
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Webinar_05_Nov_1920x1080.jpg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
END:VCALENDAR